TipRanks
BioMarin Pharmaceutical (GB:0HNC)
LSE:0HNC
UK Market

BioMarin Pharmaceutical (0HNC) Technical Analysis

2 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
BioMarin Pharmaceutical’s (0HNC) Moving Averages Convergence Divergence (MACD) indicator is -0.70, suggesting BioMarin Pharmaceutical is a Buy.
BioMarin Pharmaceutical’s (0HNC) 20-Day exponential moving average is 64.13, while BioMarin Pharmaceutical’s (0HNC) share price is $66.02, making it a Sell.
BioMarin Pharmaceutical’s (0HNC) 50-Day exponential moving average is 63.45, while BioMarin Pharmaceutical’s (0HNC) share price is $66.02, making it a Sell.

BioMarin Pharmaceutical (0HNC) Pivot Points

Sep 27, 2026, 02:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
58.81
60.00
60.61
61.80
62.41
63.60
64.21
Fibonacci
60.00
60.69
61.12
61.80
62.49
62.92
63.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioMarin Pharmaceutical (0HNC) Moving Averages

Sep 27, 2026, 02:17 AM
Period
Simple
Exponential
MA5
62.46Sell
62.13Sell
MA10
63.85Sell
63.25Sell
MA20
64.72Sell
64.13Sell
MA50
64.03Sell
63.45Sell
MA100
59.92Buy
61.38Sell
MA200
58.56Buy
59.24Buy
BioMarin Pharmaceutical’s (0HNC) 10-Day exponential moving average is 63.25, while BioMarin Pharmaceutical’s (0HNC) share price is $66.02, making it a Sell.
BioMarin Pharmaceutical’s (0HNC) 100-Day exponential moving average is 61.38, while BioMarin Pharmaceutical’s (0HNC) share price is $66.02, making it a Sell.
BioMarin Pharmaceutical’s (0HNC) stock price is $66.02 and BioMarin Pharmaceutical’s (0HNC) 50-day simple moving average is 64.03, creating a Sell signal.
BioMarin Pharmaceutical’s (0HNC) stock price is $66.02 and BioMarin Pharmaceutical’s (0HNC) 100-day simple moving average is 59.92, creating a Buy signal.
BioMarin Pharmaceutical’s (0HNC) stock price is $66.02 and BioMarin Pharmaceutical’s (0HNC) 200-day simple moving average is 58.56, creating a Buy signal.

BioMarin Pharmaceutical (0HNC) Technical Indicators

Sep 27, 2026, 02:17 AM
Name
Value
Implied Action
RSI (14)
34.19
Neutral
STOCH (9,6)
2.06
Buy
STOCHRSI (14)
2.06
Buy
MACD (12,26)
-0.70
Buy
ADX (14)
20.42
Neutral
Williams %R
-100.00
Buy
CCI (14)
-268.77
Buy
ATR (14)
1.81
-
Ultimate Oscillator
28.37
Sell
ROC
-8.84
Sell
BioMarin Pharmaceutical’s (0HNC) Relative Strength Index (RSI) is 34.19, creating a Neutral signal.
BioMarin Pharmaceutical’s (0HNC) Trend Strength Indicator (ADX) is 20.42, creating a Neutral signal.
BioMarin Pharmaceutical’s (0HNC) Commodity Channel Index (CCI) is -268.77, creating a Buy signal.
BioMarin Pharmaceutical’s (0HNC) Price Rate of Change (ROC) is -8.84, creating a Sell signal.

FAQ

Is 0HNC a Buy, Hold, or Sell?
Based on 0HNC’s technical indicators, 0HNC is a Sell.
    What is 0HNC’s RSI (14)?
    0HNC’s RSI (14) is 34.19, which suggests 0HNC is a Neutral.
      What is 0HNC’s MACD?
      0HNC’s MACD is -0.70, which suggests 0HNC is a Buy.
        What is 0HNC’s 5-day moving average?
        0HNC’s 5-day moving average is 62.46, which suggests 0HNC is a Sell.
          What is 0HNC’s 20-day moving average?
          0HNC 20-day moving average is 64.72, which suggests 0HNC is a Sell.
            What is 0HNC’s 50-day moving average?
            0HNC’s 50-day moving average is 64.03, which suggests 0HNC is a Sell.
              What is 0HNC’s 200-day moving average?
              0HNC’s 200-day moving average is 58.56, which suggests 0HNC is a Buy.
                What is 0HNC’s Williams % R (14)?
                0HNC’s Williams % R (14) is -100.00, which suggests 0HNC is a Buy.
                  What is 0HNC’s CCI (14)?
                  0HNC’s CCI (14) is -268.77, which suggests 0HNC is a Buy.
                    What is the share price of BioMarin Pharmaceutical?